MapLight Therapeutics, Inc. (MPLT) Free cash flow 2024–2025
MapLight Therapeutics, Inc. (MPLT) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$138.6MFY2025 · since FY2024: -$79.6M → -$138.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$138.6M | -74.2% |
| FY2024 | -$79.6M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice